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Background: Previous studies have reported that different genotypes of PTPN11 gene (protein tyrosine
phosphatase, non-receptor 11) were associated with different levels of serum lipids. The aim of this study was to
explore the relationship between single nucleotide polymorphisms (SNPs) of PTPN11 and serum lipids in Northeast
Chinese.
Methods: A total of 1003 subjects, 584 males and 419 females, were included in the study and their serum lipids
were determined. Five htSNPs (rs2301756, rs12423190, rs12229892, rs7958372 and rs4767860) of PTPN11 gene were
genotyped using TaqMan assay method.
Results: All of the five SNPs were in Hardy-Weinberg equilibrium. The male subjects had higher triglyceride (TG),
higher low-density lipoprotein cholesterol (LDL-C) and lower high-density lipoprotein cholesterol (HDL-C) level than
females. In males, rs4767860 was found to be associated with serum TG and total cholesterol (TC) levels and
rs12229892 was associated with TC level. However, these significant associations could not be observed in females.
In females, rs2301756 was found to be associated with TG and rs7958372 was associated with LDL-C level.
Haplotype analysis showed that the GCGTG haplotype was associated with slightly higher TG level and ATGCG with
higher TC level.
Conclusions: SNPs of PTPN11 may play a role in serum lipids in a sex-specific pattern. However, more studies are
needed to confirm the conclusion and explore the underlying mechanism.
Keywords: PTPN11, Single nucleotide polymorphism (SNP), Triglyceride (TG), Total cholesterol (TC), Low-density
lipoprotein cholesterol (LDL-C), High-density lipoprotein cholesterol (HDL-C)Introduction
Dyslipidemia such as the increased levels of total choles-
terol (TC), triglyceride (TG) or the decreased level of
high-density lipoprotein cholesterol (HDL-C) has been
concluded to be involved in the higher risk of cardiac-
cerebral vascular disease [1–3] and has become a serious
public health problem [4]. It is a complex trait that many
factors, environmental and genetic [5,6], have been
reported to be associated with it. However, these factors
could only explain part of the total variance, and more
factors need to be identified.
Src homology-2 domain-containing protein tyrosine
phosphatase 2 (SHP2), a ubiquitously expressed protein
tyrosine phosphatase, plays an essential role in many cell* Correspondence: jiangjing19702000@jlu.edu.cn
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reproduction in any medium, provided the orsignaling events such as metabolic control and transcrip-
tion regulation [7,8]. SHP2 could regulate the apoB
(apolipoprotein B) secretion in insulin-dependent pat-
tern via phosphatidylinositol 3′-kinase [9,10]. SHP2
activity was associated with the expression of the
fatty acid-metabolizing enzyme Acyl-CoA synthetase 4
(ACSL4) [11] and the synthesis of steroid [12]. SHP2
deletion mice could develop a profile of higher serum
levels of cholesterol, TG, and low-density lipoprotein [8].
Single nucleotide polymorphisms (SNPs) of protein tyro-
sine phosphatase, non-receptor 11 (PTPN11) gene, which
encodes SHP2, may be associated with serum lipid levels
via changing the activity of SHP2 on lipometabolism.
Jamshidi et al. first reported that one of the tagging
SNPs of the PTPN11 gene, rs11066320, was associated
with serum low-density lipoprotein cholesterol (LDL-C)
level in normal Caucasian female twins [13] and Lu et al.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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HDL-C level. The data from Hapmap database show that
variants of PTPN11 gene present great varieties in differ-
ent ethnicities. The role of PTPN11 gene on lipid profile
has not been described in Chinese so far. The aim of this
study was to explore the association of tagging SNPs of
PTPN11 gene and lipid levels in Chinese normal people.Methods
Subjects
From January to December 2009, people who attended the
physical examination center of the First Hospital of Jilin
University were invited to the study. A total of 1080 per-
sons signed the informed consent and agreed to participate
in this study. Subjects who had been taking lipid-lowing
medication were excluded from the analysis (n = 73). At
last, 1003 subjects, 584 males and 419 females, were in-
cluded in the analysis. The range of age was from 35 to
79 years, with a median of 49 years. This study protocol
was approved by the ethics committee of the First Hospital
of Jilin University.
Venous blood samples were obtained from all subjects
after overnight fasting. The levels of serum TC, TG, HDL-C
and LDL-C were determined by enzymatic methods in an
autoanalyzer (Type 7600; Hitachi Ltd., Japan) in our Clin-
ical Laboratory Center. The inter-day coefficient variations
(CV) of the two distinct analyte levels (Bio-Rad, USA) of
the lab were 3.17% and 3.90% for TC, 2.74% and 2.64% for
TG, 3.85% and 4.08% for HDL-C, 3.72% and 3.37% for
LDL-C during the researching period.Tagging SNPs selection and genotyping
SNP tagging was to identify a set of SNPs that efficiently
tags all known SNPs. Haplotype tagging SNPs (htSNPs)
were selected from the Han Chinese data in the HapMap
Project (06-02-2009 HapMap) using the SNPbrowser™
Software v4.0 to capture SNPs with a minimum minor
allele frequency (MAF) of 0.05 with a pair-wise r square of
0.8 or greater [14]. There were nine SNPs at MAF > 0.05
in the PTPN11 gene in Chinese on HapMap, all of which
were located in non-coding regions. Five SNPs, rs2301756,
rs12423190, rs12229892, rs7958372 and rs4767860, were
selected as htSNPs for further study.
Genomic DNA was extracted from whole blood follow-
ing the protocols provided by the manufacturer (Axygen,
USA). Genotypes of each SNP were determined using
TaqMan SNP genotying assays (Applied Biosystems, USA)
and the detailed process of polymerase chain reaction
(PCR) was described elsewhere [15]. The amplified prod-
ucts of PCR were read on ABI PRISM 7900 Sequence
Detector in the end-point mode and genotypes were iden-
tified using the Allelic Discrimination Sequence Detector
Software V2.3.Statistical analysis
Categorical data were described as frequency and percent-
age and compared using χ2 test or Fisher exact test when
appropriate. Continuous variables were summarized as
median (25th to 75th percentiles) and compared by
Kraskal-Wallis test among groups. The frequencies of ge-
notypes of each SNP were determined via direct counting
and deviation from Hardy-Weinberg equilibrium was
assessed by a goodness-of-fit χ2 test. Levels of TC, TG,
HDL-C and LDL-C were transformed to their logarithms
to improve the normality of distribution. Associations of
the SNPs and lipid levels were assessed using analysis of
covariance within each gender type, adjusted for age, body
mass index (BMI) and waist circumference. The above
analyses were performed in SAS 9.1.3 software (SAS Insti-
tute Inc, USA). For haplotypes with frequencies >1%, their
associations with lipids were assessed compared to the
most common haplotype using the linear regression model
with the HAPSTAT software 3.0 [16]. The statistical
significance was P < 0.05.
Results
The baseline characteristics of the subjects are shown in
Table 1. The body mass index (BMI) was higher than
24.0 Kg/m2 in half of the subjects (the median value of
BMI was 24.0 Kg/m2, with a quartile range from 21.9 to
26.1 Kg/m2). No difference was observed between males
and females in terms of age, but BMI and waist circum-
ference were higher in males than in females.
The linkage disequilibrium structure of the five SNPs
studied, rs2301756, rs12423190, rs12229892, rs7958372
and rs4767860 is presented in Table 2. They were all in
linkage disequilibrium, though to different extents. All
of the five SNPs were in Hardy-Weinberg equilibrium
(P = 0.540, 0.354, 0.778, 0.858, 0.489, respectively). There
were no significant differences in the distribution of geno-
types between males and females (Table 1). And no differ-
ences were observed among genotypes of each SNP in
terms of age, sex, BMI and waist circumference (data were
not shown).
As lipid levels of males were different from those of fe-
males, except for cholesterol (Table 1), separate analyses
were performed on the association of lipid levels and SNPs.
In males, the median serum level of TG was 1.61 mmol/
L, with a quartile range 1.16–2.44 mmol/L. Rs4767860
and rs12229892 were observed to be associated with TG
level after controlling for the effects of age, waist circum-
ference and BMI in male subjects. The genotype GG or
GA of rs4767860 was found to be with higher TG level
compared to the most common genotype AA (P = 0.028,
0.024, respectively), and genotype AA of rs12229892 was
associated with lower TG level compared to genotype GG
(P = 0.009, Table 3). The median level of TC was
5.03 mmol/L, and subjects bearing GG genotype of
Table 1 Characteristics of subjects included
All (n = 1003) Male (n = 584) Female (n = 419) P
Age (year) 49 (45–55) 49 (45–54) 48 (44–56) 0.640
Waist (cm) 85 (77–92) 90 (84–94) 77 (72–83) <0.001
BMI (Kg/m2) 24.0 (21.9–26.2) 24.9 (23.0–26.7) 22.6 (20.7–24.9) <0.001
TG (mmol/L) 1.44 (0.98–2.12) 1.61 (1.16–2.44) 1.21 (0.84–1.73) <0.001
TC (mmol/L) 5.04 (4.49–5.66) 5.03 (4.48–5.68) 5.09 (4.52–5.64) 0.669
HDL-C (mmol/L) 1.33 (1.15–1.56) 1.27 (1.10–1.45) 1.48 (1.27–1.70) <0.001
LDL –C (mmol/L) 3.09 (2.63–3.60) 3.10 (2.69–3.63) 3.00 (2.53–3.54) <0.001
rs2301756
GG 750 (74.8%) 439 (75.2%) 311 (74.2%) 0.625
GA 232 (23.1%) 131 (22.4%) 101 (24.1%)
AA 21 (2.1%) 14 (2.4%) 7 (1.7%)
rs12423190
TT 515 (51.3%) 304 (52.0%) 211 (50.4%) 0.782
TC 399 (39.8%) 227 (38.9%) 172 (41.0%)
CC 89 (8.9%) 53 (9.1%) 36 (8.6%)
rs12229892
GG 342 (34.1%) 189 (32.4%) 153 (36.5%) 0.271
GA 485 (48.4%) 285 (48.8%) 200 (47.7%)
AA 176 (17.5%) 110 (18.8%) 66 (15.8%)
rs7958372
TT 751 (74.9%) 439 (75.2%) 312 (74.5%) 0.962
TC 235 (23.4%) 135 (23.1%) 100 (23.9%)
CC 17 (1.7%) 10 (1.7%) 7 (1.7%)
rs4767860
AA 335 (33.4%) 198 (33.9%) 137 (32.7%) 0.666
GA 480 (47.9%) 282 (48.3%) 198 (47.3%)
GG 188 (18.7%) 104 (17.8%) 84 (20.0%)
Unless indicated, data were described as median (Q1–Q3).
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compared to subjects with genotype AA (5.13 v.s.
4.98 mmol/L, P = 0.021) in males. The median levels of
HDL-C and LDL-C were 1.27 mmol/L and 3.10 mmol/L,
respectively, and no SNP was found to be related to them.
In females, however, the results were different. Female
subjects had lower TG (1.21 v.s. 1.61 mmol/l), lower







Values on the left of “–” were Lewontin’s D’ coefficients and on the right were r2.v.s. 1.27 mmol/L) level than males. The SNPs which were
found to be significantly associated with TC or TG level in
males could not be repeated in females. However, two
other SNPs, rs2301756 and rs7958372, were found to be
significantly associated with lipid level in females. The AA
genotype of rs2301756 (P = 0.005) was found to be associ-
ated with higher serum TG level and the CC genotype of







Table 3 Associations between SNPs of PTNP11 and lipid levels stratified by gender
Frequency
(%)
TG TC HDL-C LDL-C
Median (Q1–Q3) P Median (Q1–Q3) P Median (Q1–Q3) P Median (Q1–Q3) P
Male (n = 584)
rs2301756
GG 439 (75.2) 1.59 (1.09–2.37) – 5.02 (4.45–5.63) – 1.25 (1.10–1.43) – 3.10 (2.68–3.61) –
GA 131 (22.4) 1.63 (1.20–2.47) 0.319 5.07 (4.52–5.84) 0.161 1.30 (1.10–1.47) 0.164 3.10 (2.68–3.74) 0.236
AA 14 (2.4) 1.74 (1.19–2.85) 0.516 5.03 (4.76–5.32) 0.877 1.30 (1.12–1.60) 0.572 2.98 (2.75–3.65) 0.969
rs12423190
TT 304 (52.0) 1.57 (1.08–2.44) – 4.99 (4.46–5.57) – 1.27 (1.10–1.47) – 3.10 (2.65–3.62) –
TC 227 (38.9) 1.67 (1.26–2.33) 0.184 5.10 (4.49–5.74) 0.411 1.26 (1.09–1.42) 0.309 3.14 (2.70–3.63) 0.380
CC 53 (9.1) 1.64 (1.08–2.68) 0.120 5.07 (4.49–5.76) 0.219 1.30 (1.07–1.51) 0.203 3.00 (2.72–3.70) 0.595
rs12229892
GG 189 (32.4) 1.67 (1.21–2.53) – 5.13 (4.53–5.72) – 1.30 (1.10–1.47) – 3.11 (2.70–3.67) –
GA 285 (48.8) 1.61 (1.20–2.45) 0.405 5.02 (4.49–5.64) 0.106 1.23 (1.10–1.41) 0.988 3.14 (2.67–3.66) 0.386
AA 110 (18.8) 1.41 (0.96–2.16) 0.009 4.96 (4.35–5.50) 0.118 1.29 (1.14–1.49) 0.562 3.08 (2.64–3.57) 0.354
rs7958372
TT 439 (75.2) 1.59 (1.10–2.37) – 5.03 (4.46–5.64) – 1.25 (1.10–1.43) – 3.10 (2.69–3.61) –
TC 135 (23.1) 1.64 (1.20–2.47) 0.351 5.05 (4.54–5.77) 0.200 1.30 (1.10–1.47) 0.197 3.10 (2.68–3.74) 0.260
CC 10 (1.7) 1.89 (1.22–2.85) 0.619 4.86 (4.56–5.28) 0.648 1.30 (1.12–1.45) 0.615 2.94 (2.61–3.65) 0.535
rs4767860
AA 198 (33.9) 1.53 (1.02–2.37) – 4.98 (4.42–5.51) – 1.25 (1.10–1.45) – 3.10 (2.60–3.60) –
GA 282 (48.3) 1.63 (1.20–2.41) 0.024 5.03 (4.48–5.68) 0.185 1.28 (1.09–1.43) 0.973 3.10 (2.67–3.60) 0.252
GG 104 (17.8) 1.64 (1.22–2.64) 0.028 5.13 (4.56–5.80) 0.021 1.30 (1.10–1.47) 0.598 3.15 (2.75–3.71) 0.084
Female (n = 419)
rs2301756
GG 311 (74.2) 1.19 (0.83–1.71) – 4.94 (4.49–5.60) – 1.48 (1.27–1.69) – 2.98 (2.50–3.43) –
GA 101 (24.1) 1.25 (0.85–1.85) 0.780 5.23 (4.72–5.87) 0.071 1.51 (1.27–1.76) 0.283 3.12 (2.66–3.69) 0.083
AA 7 (1.7) 2.33 (1.14–3.20) 0.005 5.02 (4.53–6.20) 0.300 1.37 (1.21–1.59) 0.605 3.16 (2.42–3.84) 0.555
rs12423190
TT 211 (50.4) 1.25 (0.82–1.75) – 5.03 (4.53–5.67) – 1.50 (1.27–1.71) – 3.04 (2.57–3.56) –
TC 172 (41.0) 1.18 (0.87–1.64) 0.592 5.12 (4.47–5.68) 0.709 1.46 (1.26–1.66) 0.149 3.00 (2.47–3.56) 0.759
CC 36 (8.6) 1.10 (0.80–1.99) 0.388 5.00 (4.64–5.32) 0.877 1.40 (1.22–1.74) 0.184 2.97 (2.52–3.35) 0.895
rs12229892
GG 153 (36.5) 1.21 (0.85–1.71) – 5.11 (4.57–5.64) – 1.48 (1.26–1.70) – 3.00 (2.65–3.48) –
GA 200 (47.7) 1.23 (0.86–1.74) 0.497 5.04 (4.45–5.67) 0.599 1.45 (1.27–1.68) 0.880 3.00 (2.51–3.60) 0.873
AA 66 (15.8) 1.19 (0.80–1.68) 0.232 5.07 (4.60–5.61) 0.463 1.53 (1.30–1.77) 0.128 3.07 (2.67–3.40) 0.526
rs7958372
TT 312 (74.5) 1.19 (0.83–1.71) – 4.95 (4.50–5.60) – 1.48 (1.27–1.69) – 2.98 (2.51–3.44) –
TC 100 (23.9) 1.25 (0.87–1.88) 0.787 5.22 (4.67–5.93) 0.090 1.52 (1.26–1.76) 0.319 3.10 (2.62–3.63) 0.278
CC 7 (1.7) 1.92 (0.85–2.33) 0.201 5.02 (4.68–6.20) 0.183 1.31 (1.21–1.59) 0.418 3.48 (3.16–4.06) 0.019
rs4767861
AA 137 (32.7) 1.23 (0.81–1.68) – 4.94 (4.53–5.61) – 1.51 (1.30–1.70) – 3.00 (2.57–3.40) –
GA 198 (47.3) 1.21 (0.86–1.79) 0.474 5.11 (4.45–5.64) 0.515 1.45 (1.24–1.70) 0.113 2.96 (2.46–3.54) 0.600
GG 84 (20.0) 1.21 (0.84–1.91) 0.134 5.16 (4.68–5.87) 0.123 1.41 (1.26–1.67) 0.236 3.13 (2.68–3.58) 0.132
Differences between genotype groups were determined using analysis of covariance within each gender type, adjusted for age, BMI and waist circumference.
P value in bold indicated the difference was significant comparing to the reference group (P<0.05).
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(Table 3). None of the five SNPs was observed to be asso-
ciated with TC or HDL-C level.
Because of the linkage disequilibrium, 18 haplotypes
were observed using HAPSTAT software which estimated
haplotype frequencies based on an EM algorithm and only
four of them had the frequencies greater than 1% (Table 4).
The GCGTG haplotype, with an estimated frequency of
27.75%, was found to be significantly associated with the
increased level of serum TG compared to the most com-
mon haplotype GTATA (41.17%) after adjusting for age,
sex, BMI and waist circumference (The slope of the linear
regression is 0.054, P = 0.042). The ATGCG haplotype
(12.71%) was found to be associated with slightly higher
TC level (The slope of the linear regression is 0.027,
P = 0.030). None of the haplotypes was found to be associ-
ated with HDL-C or LDL-C.
Discussion
The results of our study showed that lipid profile was
different between males and females that the serum TG
and LDL-C levels were higher and HDL-C lower in
males than in females. But no difference was observed in
the level of TC. These results were similar to those of
previous reports [17,18].
The associations between SNPs of PTPN11 gene and
serum lipid levels in 1003 Chinese people presented a
sex-specific pattern though the distribution of genotypes
had no differences between the two sexes. Rs4767860
and rs12229892 were associated with TG level in males,
but these significant associations could not be observed
in females. In females, the genotype AA of rs2301756
was found to be associated with higher TG compared to
the most common genotype GG. The SNP of rs4767860
was associated with TC in males but no SNP was related
to TC in females.
Genotypes of SNPs of PTPN11 varied in different eth-
nicities. In our study, the genotypes of GG, GA and AA
of rs2301756 were 75.2%, 22.4% and 2.4%, respectively.
They were similar to those of Japanese (62.1%, 32.9%
and 5.0%, respectively) [19] but absolutely different from
those of Caucasian (0.5%, 13.2% and 86.3%, respectively)
[13]. The data from Hapmap show that rs12229892 andTable 4 Haplotype analysis of SNPs of PTPN11 on the lipid le
Haplotype Frequency TG
b P b
GTATA 41.17% Reference – Reference
GCGTG 27.75% 0.054 0.042 0.013
GTGTA 15.26% 0.028 0.389 −0.006
ATGCG 12.71% 0.050 0.165 0.027
Differences between haplotype groups were assessed using the linear regression m
indicated the difference was significant comparing to the most common haplotype
SNPs were aligned as rs2301756, rs12423190, rs12229892, rs7958372 and rs4767860rs4767860 are very rare or do not exist in Caucasian and
African Americans while in Chinese and Japanese these
two SNPs are very common. The A allele of rs12229892
was 41.7% and G allele of rs4767860 was 42.7% in our
study. The C allele of rs7958372 in HapMap database is
the dominant allele in Caucasian while in Asian it is the
minor allele (13.4% in our study). Considering the diver-
sity of variants of PTPN11 in different ethnicities, the
positive associations observed in our study might not be
repeated in other ethnic populations.
The PTPN11 gene, which encodes SHP2, has been
reported to be associated with helicobacter pylori-related
gastric atrophy [15,20] and gastric cancer [21]. Jamshidi
et al. [13] first selected three htSNPs of PTPN11 gene
(rs2301756, rs11066320 and rs11066322) and assessed
their associations with serum lipid levels in a Caucasian
female population. They found that subjects with AA
genotype of rs11066320 had lower LDL-C by 2.6% com-
pared to subjects with GG genotype. They also observed
a non-significant increasing trend of TG level from
1.26 mmol/L in rs11066322 GG genotype carriers to
1.47 mmol/L of AA genotype carriers. Lu et al. [22]
reported that genotype AA of rs11066322 of PTPN11
was associated with the higher plasma HDL-C levels.
However, the htSNPs were different in Chinese popula-
tion. One of the SNPs, rs11066320, which had MAF
> 0.05 in Caucasian, did not exist in Chinese and Japanese
[19]. Rs2301756 and rs11066322 were in complete dis-
equilibrium that rs11066322 could not be chosen as
htSNP. Okada et al. [19] reported that the HDL-C levels
were different in the non-smokers and the current
smokers within the same rs2301756 genotype, however,
the role of rs2301756 was not assessed. In our study,
rs2301756 was associated with TG level in females that
subjects of AA genotype had higher TG than subjects of
GG genotype. The mechanism underlying these associa-
tions was still in the stage of hypothesis which stated that
the SNPs of PTPN11 might change the expression of the
gene and consequently influenced the protein encoded,
SHP2, which could regulate lipometabolism [9,10].
Two limitations should be noted in our study. The first
one was only htSNPs with MAF > 5% were studied. We
could not rule out the possibility that other SNPs,vels
TC HDL-C LDL-C
P b P b P
– Reference – Reference –
0.157 −0.018 0.099 0.006 0.624
0.619 −0.002 0.841 −0.017 0.265
0.030 0.014 0.343 0.028 0.082
odel adjusted for age, sex, BMI and waist circumference. P value in bold
group (P<0.05).
.
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levels, as SNPs with low minor frequency had been
reported to be associated with lipid profile [23–26]. Se-
quencing of the whole gene might be the solution. The an-
other limitation was that the influence of life style on lipid
levels could not be assessed because of the design, as pre-
vious studies had reported that lifestyle factors such as
cigarette or alcohol consuming could affect lipid profile
[27,28]. More rigorous design would be performed in the
future study.
Conclusions
In summary, we found that SNPs of PTPN11 gene were
associated with serum lipid levels in a sex-specific pattern.
Rs12229892 and rs4767860 may play an important role in
lipid profile in males, and rs2301756 and rs7958372 may
be related to TG and LDL-C levels in females. Further
studies are needed to explore the mechanism on how
PTPN11 SNPs exert their effects on lipid profile.
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